ROCHESTER, N.Y., April 3 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. , a leading developer of image-based biomarker solutions, today announced that it filed its Form 10-KSB with the U.S. Securities and Exchange Commission (SEC) on April 2, 2007. It includes the audited financial statements for the fiscal year ended December 31, 2006.
The Form 10-KSB provides 2006 operating and financial results, as well as commentary on financial risks, uncertainties and other factors which could affect the market price of VirtualScopics’ common stock. The 10-KSB, which includes complete audited financial statements and other documents filed by VirtualScopics, can be found on file with the SEC at http://www.sec.gov.
About VirtualScopics, Inc.
VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics’ industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster. For more information about VirtualScopics, visit www.virtualscopics.com.
Forward-Looking Statements
The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbors created thereby. These forward-looking statements include, but are not limited to, statements regarding the expected benefits to the Company from the renewal of the Company’s strategic alliance with a key customer, the expected benefits of new customer contracts and/or statements preceded by, followed by or that include the words “believes,” “could,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “projects,” “seeks,” or similar expressions. Forward-looking statements deal with the Company’s current plans, intentions, beliefs and expectations. Investors are cautioned that all forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Many of these risks and uncertainties are discussed in the Company’s Current Report on Form 10-KSB for December 31, 2006 filed with the Securities and Exchange Commission (the “SEC”), and in any subsequent reports filed with the SEC, all of which are available at the SEC’s website at www.sec.gov. These include without limitation: risks related to the dependence on our strategic alliance with Pfizer until we can diversify our customer base; risks of contract performance; risks of contract termination; and, our ability to successfully execute on a contract with the Department of Defense for the award we obtained and our ability to do so on terms favorable to us. All forward-looking statements included in this press release are based on our current expectations about future events, based on information available at the time of the release, and the Company assumes no obligation to update any forward- looking statements.
CONTACT: Tracy Bagatelle-Black Tim Ryan Bagatelle-Black Public Relations Trout Group Investor Relations (661) 263-1842 (646) 378-2924 tracy@bagatelleblack.comtryan@troutgroup.com
VirtualScopics, Inc.
CONTACT: Tracy Bagatelle-Black of Bagatelle-Black Public Relations,+1-661-263-1842, tracy@bagatelleblack.com, or Tim Ryan of Trout GroupInvestor Relations, +1-646-378-2924, tryan@troutgroup.com, both forVirtualScopics
Web site: http://www.virtualscopics.com//
